Literature DB >> 16636593

Two novel PHEX mutations in Taiwanese patients with X-linked hypophosphatemic rickets.

Fu-Sung Lo1, Min-Tzu Kuo, Chao-Jan Wang, Chia-Hsieh Chang, Zhon-Liau Lee, Yang-Hau Van.   

Abstract

BACKGROUND: X-linked hypophosphatemic rickets (XLH) is an X-linked dominant disease characterized by renal phosphate wasting, hypophosphatemia, aberrant vitamin D metabolism, and defective bone mineralization. The disease is caused by mutations in the PHEX gene (phosphate-regulating gene with homologies to endopeptidases on the X-chromosome) located at Xp22.1. To date, a variety of PHEX mutations have been identified in these patients.
METHODS: PCR and direct sequencing was performed for all exons and intron-exon boundaries of the PHEX gene in two XLH families.
RESULTS: Two novel mutations, including a missense mutation (L206W) in exon 5 and a frameshift mutation (nucleotide 1826_1830delAAAAG, stop after codon 610) in exon 18 were discovered and the laboratory and radiographic findings for these patients analyzed.
CONCLUSIONS: We found that PHEX gene mutations were responsible for XLH in these Taiwanese patients. Additional studies are needed to enhance understanding of the role of PHEX in XLH pathogenesis. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636593     DOI: 10.1159/000092916

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  2 in total

1.  Slow progression of chronic renal failure in a woman of short stature and leg deformities: what is the link?

Authors:  An Vanacker; Marc Segaert; Johan Verbanck; Jo Van Dorpe; Bruce Poppe; Bart Maes
Journal:  NDT Plus       Date:  2008-06-03

2.  Identification of two novel mutations in the PHEX gene in Chinese patients with hypophosphatemic rickets/osteomalacia.

Authors:  Hua Yue; Jin-bo Yu; Jin-wei He; Zeng Zhang; Wen-zhen Fu; Hao Zhang; Chun Wang; Wei-wei Hu; Jie-mei Gu; Yun-qiu Hu; Miao Li; Yu-juan Liu; Zhen-Lin Zhang
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.